Company Overview and News


Add EKSO
to your dashboard

Headline News

EKSO BIONICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ekso Bionics Holdings, Inc. To Contact The Firm

2018-01-09 accesswire
NEW YORK, NY / ACCESSWIRE / January 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ekso Bionics Holdings, Inc. (''Ekso Bionics'' or the ''Company'') (NASDAQ: EKSO). (8-0)

Lawsuit for Investors in Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) Shares Announced by Shareholders Foundation

2018-01-09 accesswire
SAN DIEGO, CA / ACCESSWIRE / January 9, 2018 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) shares. (8-0)

2017 - Another Good Year For Our Portfolios, Core Portfolio Was Up 55.98%

2018-01-03 seekingalpha
Momentum continues for our Portfolios in 2017. Core Portfolio was up 55.98% and Momentum Portfolio gained 118.06% since its launch in April. (875-9)

BRIEF-Ekso Bionic Partners With HASOMED To Launch Functional Electrical Stimulation For The EksoGT Exoskeleton

2017-12-14 reuters
* EKSO BIONICS HOLDINGS INC - ‍LAUNCH OF EKSOGT EXOSKELETON‘S FUNCTIONAL ELECTRICAL STIMULATION INTERFACE CAPABILITY THROUGH A PARTNERSHIP WITH HASOMED​ Source text for Eikon: Further company coverage: (8-1)

Diversification And A Little Color From Our Momentum Picks Helped Our Core Portfolio's 9.84% Surge In November

2017-12-04 seekingalpha
Our Core Portfolio surged 9.84% last month, the biggest monthly return in 2017 so far. And the Portfolio is up 135.44% in less than 2 years. (1219-8)

Ekso Bionics (EKSO) in Focus: Stock Moves 6.6% Higher

2017-11-28 zacks
Ekso Bionics Holdings, Inc. (EKSO - Free Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $1.04 –$4.13 in the past one-month time frame, witnessed a sharp increase yesterday. (15-0)

Ekso Bionics, Bionic Workers?, Ford Using EksoVest on the Assembly Line and Financial Review

2017-11-22 accesswire
NEW YORK, NY / ACCESSWIRE / November 22, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report with no obligation on Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical, industrial and defense applications. (13-2)

Options Traders Expect Huge Moves in Ekso Bionics (EKSO) Stock

2017-11-14 zacks
Investors in Ekso Bionics Holdings, Inc. (EKSO - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 17, 2017 $2.50 Call had some of the highest implied volatility of all equity options today. (36-1)

Ekso Bionics Stock Soars on 'Bionic' Deal With Ford | InvestorPlace

2017-11-10 investorplace
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) stock was surging today on news of an interesting deal with Ford Motor Company (NYSE:F). (13-2)

Ekso Bionics Holdings' (EKSO) CEO Tom Looby on Q3 2017 Results - Earnings Call Transcript

2017-11-09 seekingalpha
Greetings and welcome to the Ekso Bionics' Third Quarter 2017 Financial Results Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded. For opening remarks, I'll now turn the call over to David Carey of Lazar Partners. Thank you, David, you may begin. (8-2)

Medical Robotics Update: M&A And Strategic Alliances Drive Returns

2017-09-29 seekingalpha
This is Part 3 of a series on the medical robotics sector, which is an emerging space that continues to grow. (29-4)

Medical Robots Market by Product ), Application - Global Forecasts to 2021

2017-09-13 prnewswire
The medical robots market is projected to reach USD 12.80 billion by 2021 from USD 4.90 billion in 2016, growing at a CAGR of 21.1% in the next five years (2016 to 2021). (1-4)

Ekso Bionics Holdings' (EKSO) CEO Thomas Looby on Q2 2017 Results - Earnings Call Transcript

2017-08-08 seekingalpha
Greetings and welcome to the Ekso Bionics' Second Quarter 2017 Financial Results Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded. For opening remarks, I'll now turn the call over to David Carey of Lazar Partners. Thank you, David, you may begin. (0-1)

CUSIP: 282644202